Michael Plebanek

Dr. Plebanek completed his PhD. At Northwestern University where he became interested in cancer immunology. In 2018, he joined the Hanks Laboratory at Duke University where his long term research interests are focused on better understanding the complex interplay of tumor cells with immune cells during tumor progression and metastasis. More specifically, he is studying the impact of 100 nm nanovesicles, called exosomes, released by tumor cells, at promoting the generation of immunosuppressive dendritic cells with the ultimate goal of developing novel strategies to make immunotherapies more effective.

February 2019